Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC, and IIID). Their goal is to bring these treatments to market as quickly as possible. They are working with leading academics and have engaged in a strategy of licensing key tec... Read more
View all
Dyno Therapeutics
Series A • Cambridge, United States
Atalanta Therapeutics
Series A • Boston, United States
Regeneron
Post IPO Equity • Tarrytown, United States
Truvian
Series C • San Diego, United States
Verve Therapeutics
Series B • Cambridge, United States
Biogen
Cambridge, United States
Myriad Genetics
Salt Lake City, United States
Arvinas
Series C • New Haven, United States
Genentech
Venture • South San Francisco, United States
Curi Bio
Series A • Seattle, United States
Deepcell
Series B • Mountain View, United States
Bolt Threads
Series E • Emeryville, United States